Boston Scientific Corporation announced that on November 16, 2023, Nelda J. Connors informed the company that she will not stand for re-election at the Company?s 2024 Annual Meeting of Stockholders. Ms. Connors has served as a member of the Board of Directors of the Company since December 2009 and currently serves as the chair of the Risk Committee and a member of the Executive Compensation and Human Resources Committee (Compensation Committee). Ms. Connors will continue to serve as a director and in her committee roles until the 2024 Annual Meeting.

Ms. Connors? decision not to stand for re-election at the 2024 Annual Meeting is not the result of any disagreement with the Company. On November 16, 2023, David J. Roux informed the Company that he will not stand for re-election at the Company?s 2024 Annual Meeting.

Mr. Roux has served as a member of the Board since January 2014 and is currently a member of the Audit Committee and the Nominating and Governance Committee. Mr. Roux will continue to serve as a director and in his committee roles until the 2024 Annual Meeting. Mr. Roux?s decision not to stand for re-election at the 2024 Annual Meeting is not the result of any disagreement with the Company.

The Board and Nominating and Governance Committee regularly review the size and composition of the Board and will continue to evaluate whether adding directors to the Board given Ms. Connors? and Mr. Roux?s departures is in the best interest of the Company.